COMMONWEALTH EQUITY SERVICES, LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 312272 WALTHAM, MA

Position in RXRX

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$1,071,416

+$85,974 QoQ

Shares Held

291,939

-9.1% QoQ

Ownership

0.055%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#69

of 344 holders

Holding Since

Jun 2023

13 quarters on record

Healthcare · as of Jun 30, 2026

COMMONWEALTH EQUITY SERVICES, LLC holds $124,479,036 across 113 Biotechnology names. RXRX ranks #24 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	50,813	$25,240,341
2	TGTX	Tg Therapeutics, Inc.	186,987	$10,273,065
3	REGN	Regeneron Pharmaceuticals, Inc.	14,671	$9,147,955
4	EXEL	Exelixis, Inc.	105,998	$5,767,351
5	TARS	Tarsus Pharmaceuticals, Inc.	79,888	$5,028,150
6	MRNA	Moderna, Inc.	66,546	$4,660,216
7	KRYS	Krystal Biotech, Inc.	12,116	$4,503,153
8	ARWR	Arrowhead Pharmaceuticals, Inc.	55,170	$4,496,906

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,071,416	291,939	-9.1%	Shares	Sole	2026-07-29
2026-03-31	$985,442	320,991	+276.1%	Shares	Sole	2026-04-27
2025-12-31	$349,052	85,343	+85.4%	Shares	Sole	2026-02-12
2025-09-30	$224,675	46,040	-22.8%	Shares	Sole	2025-10-22
2025-06-30	$301,682	59,621	-10.1%	Shares	Sole	2025-08-06
2025-03-31	$350,954	66,343	+22.1%	Shares	Sole	2025-05-09
2024-12-31	$367,196	54,319	-7.8%	Shares	Sole	2025-02-10
2024-09-30	$388,157	58,901	+33.1%	Shares	Sole	2024-10-18
2024-06-30	$331,807	44,241	+25.7%	Shares	Sole	2024-07-31
2024-03-31	$350,774	35,183	+59.9%	Shares	Sole	2024-04-29
2023-12-31	$216,920	22,000	+3.8%	Shares	Sole	2024-02-06
2023-09-30	$162,065	21,185	+35.5%	Shares	Sole	2023-10-23
2023-06-30	$116,793	15,635	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.